AIDS and Behavior

, Volume 21, Issue 6, pp 1768–1774

Patient-Provider Engagement and Chronic Pain in Drug-Using, Primarily African American Persons Living with HIV/AIDS

  • Mary M. Mitchell
  • Trang Q. Nguyen
  • Allysha C. Maragh-Bass
  • Sarina R. Isenberg
  • Mary Catherine Beach
  • Amy R. Knowlton
Original Paper

Abstract

Among disadvantaged persons living with HIV/AIDS (PLHIV), patient-provider engagement, which has been defined as patient-provider relationships that promote the use of health care services and are characterized by active listening and supportive decision making, has been associated with antiretroviral therapy (ART) maintenance and viral suppression. However, chronic pain, depression, and substance use, all of which are prevalent in this population, can reduce the quality of patient-provider engagement. We hypothesized a model in which chronic pain, depression, and substance use would be associated with poorer patient-provider engagement, which would be positively associated with adherence, with the latter associated positively with viral suppression. We analyzed data from the BEACON study, which included surveys from 383 PLHIV who were primarily African American, on ART, and had histories of drug use. Due to six missing cases on the chronic pain variable, we used data from 377 respondents in a structural equation model. Chronic pain and depressive symptoms were significantly associated with poorer patient-provider engagement, while substance use was associated with better engagement. Patient-provider engagement in turn was associated with better ART adherence, which was associated with higher viral suppression. Results suggest the role of chronic pain in poor patient-physician engagement in this population, which has potential implications for quality of HIV patient care and health outcomes. Findings suggest the need for attention to patient-provider engagement in PLHIV.

Keywords

Patient-provider engagement Chronic pain Substance use Depressive symptoms HIV/AIDS 

References

  1. 1.
    Merlin JS, Zinski A, Norton WE, et al. A conceptual framework for understanding chronic pain in patients with HIV. Pain Pract. 2014;14(3):207–16.CrossRefPubMedGoogle Scholar
  2. 2.
    Miaskowski C, Penko JM, Guzman D, Mattson JE, Bangsberg DR, Kushel MB. Occurrence and characteristics of chronic pain in a community-based cohort of indigent adults living with HIV infection. J Pain. 2011;12(9):1004–16.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Merlin JS, Westfall AO, Chamot E, et al. Pain is independently associated with impaired physical function in HIV-infected patients. Pain Med. 2013;14(12):1985–93.CrossRefPubMedGoogle Scholar
  4. 4.
    Bailey JA, Hurley RW, Gold MS. Crossroads of pain and addiction. Pain Med. 2010;11(12):1803–18.CrossRefPubMedGoogle Scholar
  5. 5.
    Blankenship KM, Smoyer AB, Bray SJ, Mattocks K. Black-white disparities in HIV/AIDS: the role of drug policy and the corrections system. J Health Care Poor Underserved. 2005;16(4):140–56.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Kral AH, Bluthenthal RN, Booth RE, Watters JK. HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities. Am J Public Health. 1998;88(1):108–13.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Anziska Y, Helzner EP, Crystal H, et al. The relationship between race and HIV-distal sensory polyneuropathy in a large cohort of US women. J Neurol Sci. 2012;315(1):129–32.CrossRefPubMedGoogle Scholar
  8. 8.
    Goulet JL, Fultz SL, Rimland D, et al. Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis. 2007;45(12):1593–601.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Malla Y, Manchikanti L. A prospective evaluation of psychotherapeutic and illicit drug use in patients presenting with chronic pain at the time of initial evaluation. Pain Physician. 2013;16:E1–13.PubMedGoogle Scholar
  10. 10.
    Stewart DW, Jones GN, Minor KS. Smoking, depression, and gender in low-income African Americans with HIV/AIDS. Behav Med. 2011;37(3):77–80.CrossRefPubMedGoogle Scholar
  11. 11.
    Selwyn PA. Palliative care for patient with human immunodeficiency virus/acquired immune deficiency syndrome. J Palliat Med. 2005;8(6):1248–68.CrossRefPubMedGoogle Scholar
  12. 12.
    Alford DP, Compton P, Samet JH. Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med. 2006;144(2):127–34.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Savage S, Schofferman J. Pharmacological therapies of pain in drug and alcohol addictions. Pharmacological therapies for drug and alcohol addictions. New York: Dekker; 1995. p. 373–409.Google Scholar
  14. 14.
    Lorig KR, Holman HR. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003;26(1):1–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Hirsh AT, Atchison JW, Berger JJ, et al. Patient satisfaction with treatment for chronic pain: predictors and relationship to compliance. Clin J Pain. 2005;21(4):302–10.CrossRefPubMedGoogle Scholar
  16. 16.
    Peters S, Rogers A, Salmon P, et al. What do patients choose to tell their doctors? Qualitative analysis of potential barriers to reattributing medically unexplained symptoms. J Gen Intern Med. 2009;24(4):443–9.CrossRefPubMedGoogle Scholar
  17. 17.
    Beach MC, Keruly J, Moore RD. Is the quality of the patient provider relationship associated with better adherence and health outcomes for patients with HIV? J Gen Intern Med. 2006;21(6):661–5.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Bakken S, Holzemer WL, Brown M, et al. Relationships between perception of engagement with health care provider and demographic characteristics, health status, and adherence to therapeutic regimen in persons with HIV/AIDS. AIDS Patient Care STDS. 2000;14(4):189–97.CrossRefPubMedGoogle Scholar
  19. 19.
    Korthuis P Todd, et al. Substance use and the quality of patient-provider communication in HIV clinics. AIDS Behav. 2011;15(4):832–41.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Schenker Y, Stewart A, Na B, Whooley MA. Depressive symptoms and perceived doctor-patient communication in the heart and soul study. J Gen Intern Med. 2009;24(5):550–6.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Mitchell MM, Maragh-Bass AC, Nguyen TQ, Isenberg S, Knowlton AR. The role of chronic pain and current substance use in predicting negative social support among disadvantaged persons living with HIV/AIDS. AIDS Care. 2016;. doi:10.1080/09540121.2016.1168916.Google Scholar
  22. 22.
    Arribas JR, Pulido F, Delgado R, et al. Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study). J AIDS J Acquir Immune Defic Syndr. 2005;40(3):280–7.CrossRefGoogle Scholar
  23. 23.
    Holzemer WL, Henry SB, Nokes KM, et al. Validation of the sign and symptom check-list for persons with HIV disease (SSC HIV). J Adv Nurs. 1999;30(5):1041–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Mitchell MM, Knowlton A. Caregiver role overload and network support in a sample of predominantly low-income, African-American caregivers of persons living with HIV/AIDS: a structural equation modeling analysis. AIDS Behav. 2012;16(2):278–87.CrossRefPubMedGoogle Scholar
  25. 25.
    Radloff LS. The CES-D scale a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.CrossRefGoogle Scholar
  26. 26.
    IBM Corporation. IBM SPSS Statistics for Windows, Version 20.0. Armonk: IBM Corporation; 1999.Google Scholar
  27. 27.
    Muthén L, Muthén B. Mplus user’s guide. Los Angeles: Muthén & Muthén 1998–2012.Google Scholar
  28. 28.
    Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model. 1999;6(1):1–55.CrossRefGoogle Scholar
  29. 29.
    Hughes HK, Korthuis PT, Saha S, et al. A mixed methods study of patient–provider communication about opioid analgesics. Patient Educ Couns. 2015;98(4):453–61.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Krashin D, Trescot AM. Opioid therapy in chronic painful disease. Expert Decision Making on Opioid Treatment. 2013.Google Scholar
  31. 31.
    Lum PJ, Little S, Botsko M, et al. Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S91–7.CrossRefPubMedGoogle Scholar
  32. 32.
    Dorflinger L, Kerns RD, Auerbach SM. Providers’ roles in enhancing patients’ adherence to pain self management. Transl Behav Med. 2013;3(1):39–46.CrossRefPubMedGoogle Scholar
  33. 33.
    Swenson SL, Rose M, Vittinghoff E, Stewart A, Schillinger D. The influence of depressive symptoms on clinician-patient communication among patients with type 2 diabetes. Med Care. 2008;46(3):257–65.CrossRefPubMedGoogle Scholar
  34. 34.
    Barrier PA, Li JT, Jensen NM. Two words to improve physician-patient communication: what else? Mayo Clinic Proc. 2003;78(2):211–4.CrossRefGoogle Scholar
  35. 35.
    Radbruch L, Downing J. Principles of palliative care. Guide to pain management in low-resource settings. 2010:47.Google Scholar
  36. 36.
    Merlin JS, Walcott M, Kerns R, Bair MJ, Burgio KL, Turan JM. Pain self-management in HIV-infected individuals with chronic pain: a qualitative study. Pain Med. 2015;16(4):706–14.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Mary M. Mitchell
    • 1
  • Trang Q. Nguyen
    • 2
  • Allysha C. Maragh-Bass
    • 1
  • Sarina R. Isenberg
    • 1
  • Mary Catherine Beach
    • 3
  • Amy R. Knowlton
    • 4
  1. 1.Department of Health, Behavior and SocietyJohns Hopkins Bloomberg School of Public HealthBaltimoreUSA
  2. 2.Department of Mental HealthJohns Hopkins Bloomberg School of Public HealthBaltimoreUSA
  3. 3.Johns Hopkins School of MedicineBaltimoreUSA
  4. 4.Department of Health, Behavior and SocietyJohns Hopkins Bloomberg School of Public HealthBaltimoreUSA

Personalised recommendations